IP Library Granted Patent US 7,910,641
Granted Patent B2
US 7,910,641 · App. 11/639,013 · Granted Mar 22, 2011

PH modulated films for delivery of actives

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,910,641
App. No.
11/639,013
Granted
Mar 22, 2011
Kind
B2
Abstract

The invention relates to pH modulated films and methods of their preparation. The film compositions include at least one component having a non-neutral pH when combined with water; and a pH modulated polymer system selected to reduce or prevent synerisis when combined with the non-neutral component in combination with aqueous media. The films demonstrate a non-self-aggregating uniform heterogeneity. Desirably, the films disintegrate in water and may be formed by a controlled drying process, extrusion process, or other process that maintains the required uniformity of the film.

Claims (52)

1. A composition comprising:

(a) at least one component having a non-neutral pH when combined with water; and

(b) a pH modulated polymer system selected to reduce or prevent synerisis when combined with said non-neutral component in combination with water, wherein said pH modulated polymer system comprises a neutral polymer and propylene glycol alginate, wherein said neutral polymer is a combination of hydroxypropyl methylcellulose and polyethylene oxide.

2. The composition of claim 1 , wherein the composition is in the form of a film.

3. The composition of claim 2 , wherein the film includes an active.

4. The composition of claim 3 , wherein the active is the non-neutral component.

5. The composition of claim 3 , wherein the active is a different component from the non-neutral component.

6. The composition of claim 1 , wherein said at least one non-neutral component is acidic, and said polymer system comprises a neutral or acidic polymer.

7. The composition of claim 1 , wherein said at least one non-neutral component is acidic, and said polymer system comprises a neutral polymer, a basic polymer and a weak base.

8. The composition of claim 1 , wherein said at least one non-neutral component is basic, and said polymer system comprises a neutral polymer, a basic polymer and a weak acid.

9. The composition of claim 1 , wherein said at least one non-neutral component is basic, and said polymer system comprises at least one basic polymer.

10. The composition of claim 1 , wherein said polymer system provides a neutral pH when combined with said non-neutral component in combination with water.

11. The composition of claim 1 , wherein said polymer system comprises a buffer system.

12. The composition of claim 11 , wherein said buffer system comprises a weak acid, a weak base, or salts thereof

13. The composition of claim 12 , wherein said weak acid is selected from the group consisting of acetic acid, ascorbic acid, benzoic acid, butyric acid, carbonic acid, citric acid, formic acid, lactic acid, malic acid, nitrous acid, oxalic acid, phosphoric acid, propanoic acid, propionic acid, pyrophosphoric acid, pyruvic acid, valeric acid and combinations thereof.

14. The composition of claim 12 , wherein said buffer system comprises a salt of an organic acid.

15. The composition of claim 14 , wherein said organic acid salt is citrate.

16. The composition of claim 1 , wherein said pH modulated system comprises 98% of said neutral polymer.

17. A composition comprising:

(a) at least one component having a non-neutral pH when combined with water; and

(b) a pH modulated polymer system selected to reduce or prevent synerisis when combined with said non-neutral component in combination with water, wherein said pH modulated polymer system comprises a neutral polymer and propylene glycol alginate, wherein said neutral polymer is polyethylene oxide.

18. The composition of claim 17 , wherein the composition is in the form of a film.

19. The composition of claim 18 , wherein the film includes an active.

20. The composition of claim 19 , wherein the active is the non-neutral component.

21. The composition of claim 19 , wherein the active is a different component from the non-neutral component.

22. The composition of claim 17 , wherein said at least one non-neutral component is acidic, and said polymer system comprises a neutral or acidic polymer.

23. The composition of claim 17 , wherein said at least one non-neutral component is acidic, and said polymer system comprises a neutral polymer, a basic polymer and a weak base.

24. The composition of claim 17 , wherein said at least one non-neutral component is basic, and said polymer system comprises a neutral polymer, a basic polymer and a weak acid.

25. The composition of claim 17 , wherein said at least one non-neutral component is basic, and said polymer system comprises at least one basic polymer.

26. The composition of claim 17 , wherein said polymer system provides a neutral pH when combined with said non-neutral component in combination with water.

27. The composition of claim 17 , wherein said polymer system comprises a buffer system.

28. The composition of claim 27 , wherein said buffer system comprises a weak acid, a weak base, or salts thereof.

29. The composition of claim 28 , wherein said weak acid is selected from the group consisting of acetic acid, ascorbic acid, benzoic acid, butyric acid, carbonic acid, citric acid, formic acid, lactic acid, malic acid, nitrous acid, oxalic acid, phosphoric acid, propanoic acid, propionic acid, pyrophosphoric acid, pyruvic acid, valeric acid and combinations thereof.

30. The composition of claim 27 , wherein said buffer system comprises a salt of an organic acid.

31. The composition of claim 30 , wherein said organic acid salt is citrate.

32. A composition comprising:

(a) a component having an acidic pH when combined with water; and

(b) a polymer system comprising at least one neutral or acidic polymer and propylene glycol alginate, wherein said neutral polymer is polyethylene oxide.

33. The composition of claim 32 , wherein the composition is in the form of a film.

34. The composition of claim 33 , wherein the film includes an active.

35. The composition of claim 34 , wherein the active is the acidic component.

36. The composition of claim 34 , wherein the active is a different component from the acidic component.

37. The composition of claim 32 , wherein said a polymer system comprises 98% of said at least one neutral or acidic polymer.

38. A device comprising:

(a) a film composition comprising

(i) at least one component having a non-neutral pH when combined with water; and

(ii) a pH modulated polymer system selected to reduce or prevent synerisis when combined with said non-neutral component in combination with water, wherein said pH modulated polymer system comprises a neutral polymer and propylene glycol alginate; and

(b) a delivery substrate, wherein said delivery substrate is a bandage.

39. The composition of claim 38 , wherein the film composition includes an active.

40. The composition of claim 39 , wherein the active is the non-neutral component.

41. The composition of claim 39 , wherein the active is a different component from the non-neutral component.

42. The device of claim 38 , wherein said pH modulated system comprises 98% of said neutral polymer.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded May 13, 2026
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
To: AQUESTIVE THERAPEUTICS, INC.
Reel/Frame 075646/0258 →
SECURITY INTEREST Recorded Nov 2, 2023
From: AQUESTIVE THERAPEUTICS, INC.
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 065446/0494 →
RELEASE OF SECURITY INTEREST Recorded Nov 1, 2023
From: U.S. BANK TRUST COMPANY NATIONAL ASSOCIATION (AS SUCCESSOR IN INTEREST TO U.S BANK NATIONAL ASSOCIATION)
To: AQUESTIVE THERAPEUTICS, INC.
Reel/Frame 065426/0642 →
SECURITY INTEREST Recorded Jul 15, 2019
From: AQUESTIVE THERAPEUTICS, INC.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 049758/0082 →
RELEASE OF SECURITY INTEREST Recorded Jul 15, 2019
From: PERCEPTIVE CREDIT HOLDINGS, LP
To: AQUESTIVE THERAPEUTICS, INC.; MONOSOL RX, INC.; MSRX US, LLC
Reel/Frame 049757/0733 →
AMENDMENT TO PATENT SECURITY AGREEMENT RECORDED AT REEL/FRAME 039707/0194 Recorded Jan 30, 2018
From: AQUESTIVE THERAPEUTICS, INC.
To: PERCEPTIVE CREDIT HOLDINGS, LP
Reel/Frame 045279/0802 →
CHANGE OF NAME Recorded Jan 29, 2018
From: MONOSOL RX, LLC
To: AQUESTIVE THERAPEUTICS, INC.
Reel/Frame 045196/0389 →
RELEASE OF SECURITY INTEREST Recorded Aug 22, 2016
From: WHITE OAK GLOBAL ADVISORS, LLC
To: MONOSOL RX, LLC
Reel/Frame 039774/0782 →
SECURITY INTEREST Recorded Aug 16, 2016
From: MONOSOL RX, LLC; MONOSOL RX, INC.; MSRX US, LLC
To: PERCEPTIVE CREDIT HOLDINGS, LP
Reel/Frame 039707/0194 →
SECURITY AGREEMENT Recorded Dec 18, 2012
From: MONOSOL RX, LLC
To: WHITE OAK GLOBAL ADVISORS, LLC, AS AGENT
Reel/Frame 029490/0156 →